Recently, CD69+CD103+ tissue-resident memory T cells (TRM), were identified as nonrecirculating non-recirculating immune cells that reside in peripheral tissues, and have been reported to mediate tumor protection by promoting the tumor-immune equilibrium through the secretion of cytokines and/or CD103-enhanced tumor cell killing. The gene discussed is CD69; the disease is neoplasm.